# Marygold Companies, Inc.: financial statements, quarterly

MGLD · NYSE · CIK 1005101 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/mgld.md) · [Financials](/companies/mgld/financials.md) · [Filings](/companies/mgld/filings.md) · [Insiders](/companies/mgld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [8,235](/filings/0001493152-24-044271.md) | [8,457](/filings/0001493152-25-005002.md) | [7,880](/filings/0001641172-25-009260.md) | [8,265 d](/filings/0001493152-25-014286.md) | [7,910](/filings/0001493152-25-021259.md) | [8,004](/filings/0001493152-26-005255.md) | [5,522](/filings/0001493152-26-021973.md) | [5,508 d](/filings/0001493152-26-043341.md) | [6,963](/filings/0001493152-25-021259.md) | [7,643](/filings/0001493152-26-005255.md) | [7,189](/filings/0001493152-26-021973.md) | [6,925 d](/filings/0001493152-26-043341.md) |
| Cost of revenue | $k | [2,037](/filings/0001493152-24-044271.md) | [2,091](/filings/0001493152-25-005002.md) | [2,323](/filings/0001641172-25-009260.md) | [2,271 d](/filings/0001493152-25-014286.md) | [2,128](/filings/0001493152-25-021259.md) | [2,076](/filings/0001493152-26-005255.md) | [648](/filings/0001493152-26-021973.md) | [1,002 d](/filings/0001493152-26-043341.md) | [1,599](/filings/0001493152-25-021259.md) | [1,987](/filings/0001493152-26-005255.md) | [398](/filings/0001493152-26-021973.md) | [464 d](/filings/0001493152-26-043341.md) |
| Gross profit | $k | [6,198](/filings/0001493152-24-044271.md) | [6,366](/filings/0001493152-25-005002.md) | [5,557](/filings/0001641172-25-009260.md) | [5,994 d](/filings/0001493152-25-014286.md) | [5,782](/filings/0001493152-25-021259.md) | [5,928](/filings/0001493152-26-005255.md) | [4,874](/filings/0001493152-26-021973.md) | [4,506 d](/filings/0001493152-26-043341.md) | [5,364](/filings/0001493152-25-021259.md) | [5,656](/filings/0001493152-26-005255.md) | [6,791](/filings/0001493152-26-021973.md) | [6,461 d](/filings/0001493152-26-043341.md) |
| Operating income | $k | [(1,036)](/filings/0001493152-24-044271.md) | [(997)](/filings/0001493152-25-005002.md) | [(1,471)](/filings/0001641172-25-009260.md) | [(2,752) d](/filings/0001493152-25-014286.md) | [(2,170)](/filings/0001493152-25-021259.md) | [(1,826)](/filings/0001493152-26-005255.md) | [(1,572)](/filings/0001493152-26-021973.md) | [(1,217) d](/filings/0001493152-26-043341.md) | [(1,264)](/filings/0001493152-25-021259.md) | [(631)](/filings/0001493152-26-005255.md) | [(136)](/filings/0001493152-26-021973.md) | [(3,853) d](/filings/0001493152-26-043341.md) |
| Interest expense | $k | [3.6](/filings/0001493152-23-040591.md) | [3.0](/filings/0001493152-24-006611.md) | [5.0](/filings/0001493152-24-018895.md) | [4.0 d](/filings/0001493152-25-014286.md) | [31.0](/filings/0001493152-25-021259.md) | [362](/filings/0001493152-26-005255.md) | [323](/filings/0001493152-26-021973.md) | [485 d](/filings/0001493152-26-043341.md) | [69.0](/filings/0001493152-25-021259.md) | [1.0](/filings/0001493152-26-005255.md) | [(3.0) d](/filings/0001493152-26-021973.md) | [33.0 d](/filings/0001493152-26-043341.md) |
| Income tax | $k | [(303)](/filings/0001493152-24-044271.md) | [(182)](/filings/0001493152-25-005002.md) | [(355)](/filings/0001641172-25-009260.md) | [(539) d](/filings/0001493152-25-014286.md) | [(483)](/filings/0001493152-25-021259.md) | [(482)](/filings/0001493152-26-005255.md) | [(307)](/filings/0001493152-26-021973.md) | [(289) d](/filings/0001493152-26-043341.md) | [(153)](/filings/0001493152-25-021259.md) | [12.0](/filings/0001493152-26-005255.md) | [(43.0)](/filings/0001493152-26-021973.md) | [(93.0) d](/filings/0001493152-26-043341.md) |
| Net income | $k | [(500)](/filings/0001641172-25-009260.md) | [(1,183)](/filings/0001641172-25-009260.md) | [(529)](/filings/0001641172-25-009260.md) | [(1,857) d](/filings/0001493152-25-014286.md) | [(1,586)](/filings/0001493152-26-021973.md) | [(1,747)](/filings/0001493152-26-021973.md) | [(1,012)](/filings/0001493152-26-021973.md) | [(1,476) d](/filings/0001493152-26-043341.md) | [(356)](/filings/0001493152-26-021973.md) | [(576)](/filings/0001493152-26-021973.md) | [222](/filings/0001493152-26-021973.md) | [(3,661) d](/filings/0001493152-26-043341.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001493152-24-044271.md) | [(0.03)](/filings/0001493152-25-005002.md) | [(0.01)](/filings/0001641172-25-009260.md) | not reported | [(0.04)](/filings/0001493152-25-021259.md) | [(0.04)](/filings/0001493152-26-005255.md) | [(0.02)](/filings/0001493152-26-021973.md) | not reported | [(0.01)](/filings/0001493152-25-021259.md) | [(0.01)](/filings/0001493152-26-005255.md) | [0.01](/filings/0001493152-26-021973.md) | not reported |
| Basic EPS | $ per share | [(0.01)](/filings/0001493152-24-044271.md) | [(0.03)](/filings/0001493152-25-005002.md) | [(0.01)](/filings/0001641172-25-009260.md) | not reported | [(0.04)](/filings/0001493152-25-021259.md) | [(0.04)](/filings/0001493152-26-005255.md) | [(0.02)](/filings/0001493152-26-021973.md) | not reported | [(0.01)](/filings/0001493152-25-021259.md) | [(0.01)](/filings/0001493152-26-005255.md) | [0.01](/filings/0001493152-26-021973.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.0](/filings/0001493152-24-044271.md) | [6.2](/filings/0001493152-25-005002.md) | [4.5](/filings/0001641172-25-009260.md) | [5.5](/filings/0001493152-25-014286.md) | [6.7](/filings/0001493152-25-021259.md) | [5.7](/filings/0001493152-26-005255.md) | [4.3](/filings/0001493152-26-021973.md) | [5.0](/filings/0001493152-26-043341.md) | [4.9](/filings/0001493152-25-021259.md) | [4.1](/filings/0001493152-26-005255.md) | [3.0](/filings/0001493152-26-021973.md) | [2.9](/filings/0001493152-26-043341.md) |
| Current assets | $m | [27.3](/filings/0001493152-23-040591.md) | [26.3](/filings/0001493152-24-006611.md) | [25.8](/filings/0001493152-24-018895.md) | [24.3](/filings/0001493152-25-014286.md) | [25.0](/filings/0001493152-24-044271.md) | [22.6](/filings/0001493152-25-005002.md) | [21.9](/filings/0001641172-25-009260.md) | [17.4](/filings/0001493152-26-043341.md) | [18.4](/filings/0001493152-25-021259.md) | [17.4](/filings/0001493152-26-005255.md) | [16.5](/filings/0001493152-26-021973.md) | [16.0](/filings/0001493152-26-043341.md) |
| Total assets | $m | [35.5](/filings/0001493152-23-040591.md) | [34.9](/filings/0001493152-24-006611.md) | [33.7](/filings/0001493152-24-018895.md) | [32.9](/filings/0001493152-25-014286.md) | [35.9](/filings/0001493152-24-044271.md) | [33.0](/filings/0001493152-25-005002.md) | [33.5](/filings/0001641172-25-009260.md) | [30.4](/filings/0001493152-26-043341.md) | [28.4](/filings/0001493152-25-021259.md) | [27.8](/filings/0001493152-26-005255.md) | [28.1](/filings/0001493152-26-021973.md) | [24.0](/filings/0001493152-26-043341.md) |
| Current liabilities | $m | [4.9](/filings/0001493152-23-040591.md) | [5.0](/filings/0001493152-24-006611.md) | [4.5](/filings/0001493152-24-018895.md) | [5.2](/filings/0001493152-25-014286.md) | [7.9](/filings/0001493152-24-044271.md) | [8.2](/filings/0001493152-25-005002.md) | [8.2](/filings/0001641172-25-009260.md) | [5.8](/filings/0001493152-26-043341.md) | [4.9](/filings/0001493152-25-021259.md) | [4.5](/filings/0001493152-26-005255.md) | [3.9](/filings/0001493152-26-021973.md) | [3.7](/filings/0001493152-26-043341.md) |
| Total liabilities | $m | [5.6](/filings/0001493152-23-040591.md) | [5.9](/filings/0001493152-24-006611.md) | [5.3](/filings/0001493152-24-018895.md) | [6.3](/filings/0001493152-25-014286.md) | [10.3](/filings/0001493152-24-044271.md) | [9.6](/filings/0001493152-25-005002.md) | [9.2](/filings/0001641172-25-009260.md) | [7.4](/filings/0001493152-26-043341.md) | [5.5](/filings/0001493152-25-021259.md) | [5.1](/filings/0001493152-26-005255.md) | [5.2](/filings/0001493152-26-021973.md) | [4.8](/filings/0001493152-26-043341.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [29.9](/filings/0001641172-25-009260.md) | [29.0](/filings/0001641172-25-009260.md) | [28.4](/filings/0001641172-25-009260.md) | [26.6](/filings/0001493152-26-043341.md) | [25.5](/filings/0001493152-26-021973.md) | [23.4](/filings/0001493152-26-021973.md) | [24.3](/filings/0001493152-26-021973.md) | [23.0](/filings/0001493152-26-043341.md) | [22.9](/filings/0001493152-26-021973.md) | [22.7](/filings/0001493152-26-021973.md) | [22.9](/filings/0001493152-26-021973.md) | [19.2](/filings/0001493152-26-043341.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [291](/filings/0001493152-24-044271.md) | [(855) d](/filings/0001493152-25-005002.md) | [(658) d](/filings/0001641172-25-009260.md) | [(689) d](/filings/0001493152-25-014286.md) | [(893)](/filings/0001493152-25-021259.md) | [(770) d](/filings/0001493152-26-005255.md) | [(1,155) d](/filings/0001493152-26-021973.md) | [(501) d](/filings/0001493152-26-043341.md) | [(533)](/filings/0001493152-25-021259.md) | [(908) d](/filings/0001493152-26-005255.md) | [(1,007) d](/filings/0001493152-26-021973.md) | [129 d](/filings/0001493152-26-043341.md) |
| Capital expenditure | $k | [25.0](/filings/0001493152-24-044271.md) | [5.0 d](/filings/0001493152-25-005002.md) | [0.0 d](/filings/0001641172-25-009260.md) | [24.0 d](/filings/0001493152-25-014286.md) | [47.0](/filings/0001493152-25-021259.md) | [6.0 d](/filings/0001493152-26-005255.md) | [0.0 d](/filings/0001493152-26-021973.md) | [1.0 d](/filings/0001493152-26-043341.md) | [29.0](/filings/0001493152-25-021259.md) | [0.0 d](/filings/0001493152-26-005255.md) | [0.0 d](/filings/0001493152-26-021973.md) | [0.0 d](/filings/0001493152-26-043341.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.4](/filings/0001493152-23-040591.md) | [40.4](/filings/0001493152-24-006611.md) | [40.4](/filings/0001493152-24-018895.md) | [40.4](/filings/0001493152-24-044271.md) | [40.4](/filings/0001493152-25-005002.md) | [40.4](/filings/0001641172-25-009260.md) | [40.8](/filings/0001493152-25-021259.md) | [40.9](/filings/0001493152-26-005255.md) | [40.8](/filings/0001493152-26-021973.md) | [43.0](/filings/0001493152-25-021259.md) | [42.9](/filings/0001493152-26-005255.md) | [43.1](/filings/0001493152-26-021973.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,712,250 at 2026-06-30, from the cover of the [10-K filed 2026-09-18](/filings/0001493152-26-043341.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.